Posts by Bryan Hayes, PharmD, DABAT, FAACT, FASHP
-
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD
Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP, clinical manager of Emergency Medicine & Overnight Pharmacy Services at Massachusetts General Hospital, clarifies the risks and benefits of drugs like ibuprofen for use in patients with COVID-19.
Biography
Dr. Bryan Hayes, PharmD, DABAT, FAACT, FASHP serves as the Director for the PGY-2 Emergency Medicine Pharmacy Residency Program at Massachusetts General Hospital. Bryan is originally from Coventry, RI, and graduated from Worcester Polytechnic Institute with a Bachelor of Science in Chemistry degree. He received his Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences in 2005. Bryan completed a PGY-1 Pharmacy Residency at UMass Memorial Medical Center in Worcester, MA in 2006 and a Clinical Toxicology Fellowship at the Maryland Poison Center/University of Maryland School of Pharmacy in Baltimore, MD, in 2008. He worked at the University of Maryland Medical Center from 2008-2016 and is currently the Clinical Manager for Emergency Medicine and Overnight Pharmacy Services at Massachusetts General Hospital. Dr. Hayes is board-certified in Clinical Toxicology and holds an Assistant Professor of Emergency Medicine appointment at Harvard Medical School.